These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Ovarian carcinoma in an adolescent with transgenerational exposure to diethylstilbestrol. Blatt J; Van Le L; Weiner T; Sailer S J Pediatr Hematol Oncol; 2003 Aug; 25(8):635-6. PubMed ID: 12902917 [TBL] [Abstract][Full Text] [Related]
5. Clear cell adenocarcinoma of the ovary associated with in utero diethylstilbestrol exposure: case report and clinical overview. Dasanu CA; Herzog TJ Medscape J Med; 2009; 11(1):6. PubMed ID: 19295927 [TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer in women given diethylstilboestrol in pregnancy: two case reports. Cohen I; Altaras M; Jaffe R; Markov S; Corduba M; Ben Aderet N J Pathol; 1987 Jun; 152(2):95-7. PubMed ID: 3625397 [TBL] [Abstract][Full Text] [Related]
7. Pituitary tumors in mice exposed prenatally to diethylstilbestrol. Walker BE; Kurth LA Cancer Res; 1993 Apr; 53(7):1546-9. PubMed ID: 8453621 [TBL] [Abstract][Full Text] [Related]
8. Preservation of fertility after partial resection of bilateral ovarian cystadenofibromas: a case report. Ewing TL; Suh-Burgmann B J Reprod Med; 2011; 56(7-8):364-5. PubMed ID: 21838171 [TBL] [Abstract][Full Text] [Related]
10. Sonographic features of ovarian cystadenofibromas: spectrum of findings. Alcázar JL; Errasti T; Mínguez JA; Galán MJ; García-Manero M; Ceamanos C J Ultrasound Med; 2001 Aug; 20(8):915-9. PubMed ID: 11503928 [TBL] [Abstract][Full Text] [Related]
11. Benign breast disease in women on estrogen therapy. A pathologic study. Fechner RE Cancer; 1972 Feb; 29(2):273-9. PubMed ID: 5013532 [No Abstract] [Full Text] [Related]
12. Peritoneal papillary serous carcinoma in a woman with a history of utero DES exposure. Seoud MA; Tawfik O; Hunter V Gynecol Oncol; 1993 Sep; 50(3):371-3. PubMed ID: 8406204 [TBL] [Abstract][Full Text] [Related]
13. Cystadenofibromas of the ovary with epithelial atypia. Kao GF; Norris HJ Am J Surg Pathol; 1978 Dec; 2(4):357-63. PubMed ID: 736210 [TBL] [Abstract][Full Text] [Related]
14. Proliferating endometrioid cystadenofibroma of the ovary. Report of a case in a teenager. Nasca D Diagn Gynecol Obstet; 1982; 4(4):317-24. PubMed ID: 7166119 [TBL] [Abstract][Full Text] [Related]
15. Cystadenofibroma of the ovary in young women. Groutz A; Wolman I; Wolf Y; Luxman D; Sagi J; Jaffa AJ; David MP Eur J Obstet Gynecol Reprod Biol; 1994 Apr; 54(2):137-9. PubMed ID: 8070598 [TBL] [Abstract][Full Text] [Related]
16. Stilboestrol (diethylstilbestrol) and the risk of ovarian cancer. Hoover R; Gray LA; Fraumeni JF Lancet; 1977 Sep; 2(8037):533-4. PubMed ID: 95735 [TBL] [Abstract][Full Text] [Related]
17. Concurrent tamoxifen-related Müllerian adenofibromas in uterus and ovary. Shi H; Chen X; Lv B; Zhang X Int J Clin Exp Pathol; 2015; 8(11):15381-5. PubMed ID: 26823898 [TBL] [Abstract][Full Text] [Related]
18. Invasive ovarian endometrioid adenofibroma with omental implants and collision with endometrial adenocarcinoma. Gaing AA; Kimble CC; Belmonte AH; Agustin E; Tchertkoff V Obstet Gynecol; 1988 Mar; 71(3 Pt 2):440-4. PubMed ID: 3347431 [TBL] [Abstract][Full Text] [Related]
19. Health risks and effects of prenatal exposure to diethylstilbestrol. Johnston GA J Fam Pract; 1983 Jan; 16(1):51-4. PubMed ID: 6848637 [TBL] [Abstract][Full Text] [Related]